Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM.

Slides:



Advertisements
Similar presentations
Integrating the Healthcare Enterprise IHE Overview Keith W. Boone Interoperability Architect, GE Healthcare Co-chair, IHE Patient Care Coordination PC.
Advertisements

CLINTON W. BROWNLEY AMERICAN UNIVERSITY PH.D. CANDIDATE SEPTEMBER 2, 2009 BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards.
XML in Pharma – Weve Done SPL, Whats Next? SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES PHILADELPHIA, PA. FEBRUARY 2006.
September, 2005What IHE Delivers 1 Presenters: Keith W. Boone, John Donnelly, Larry McKnight, Dan Russler IHE Patient Care Coordination.
Collaboration The Key to Interoperability Chuck Meyer Chair, HL7.
Depicting EHRs Immunization capability HL7 WGM – September 11, 2006 Immunization Storyboard project update.
© Copyright 2005 dbMotion Ltd. By dbMotion RIM Based Semantic Interoperability Assaf Halevy, Co – Founder & VP Strategic Accounts
Cardiology Special Interest Group Presentation to Technical Steering Committee September 12, 2005.
HL7 ICSR DSTU Update FDA progress since last working group meeting: –Completed mapping to all FDA AE programs, data collection forms and E2B –Completed.
HL7 Version 3 Laboratory Result-based Adverse Event Assessment Message Specifications RCRIM Technical Meeting September 18, 2007 Jennifer Neat Project.
HL7 January Working Group Meeting
11 SHARE S&V Document and the Pilot An Update on CDISC SHARE January 2010 Bron W. Kisler.
CDISC Content to Message HL7 Development Overview Jason Rock
Presentation to RCRIM San Antonio, TX January 15, 2008 Meredith Nahm, M.S. CV/TB Global Data Standards Efforts Therapeutic Area Data Standards: Cardiovascular.
1 HL7 Jan 2010 Working Group MeetingsCTLAB Pharmacogenomics Update JOINT RCRIM and CG Session CTLAB Message Pharmacogenomics Results Overview.
HL7 Working Group Meeting Orlando, Florida 14 January
HL7 Clinical Genomics and Structured Documents Work Groups CDA Implementation Guide: Genetic Testing Report DRAFT PROPOSAL Amnon Shabo (Shvo), PhD
CDISC-HL7 Project Update Armando Oliva, M.D. FDA Sponsor HL7 Workgroup Meeting January 14, 2008 San Antonio TX.
Regulated Product Submissions Release 2 Iteration 1 Design January 12th HL7 WGM Jason Rock
Depicting EHRs Immunization capability HL7 WGM - May 8, 2006 Immunization Storyboard project Storyboard Subgroup.
HL7 EHR SIG New Projects- Tentative Gary Dickinson 5 May 2004.
San Antonio – Todd Cooper Chair, ISO/IEEE 11073; Co-Chair HL7 DEV WG HL7 DEV WG ISO TC215 WG7 IEEE EMBS Health Informatics – Devices Update.
Regulated Product Submissions R1 Overview January 12 th HL7 WGM Jason Rock
BRIDG Overview Clinical Observation Interoperability March 18, 2008.
Regulatory Clinical Trials Clinical Trials. Clinical Trials Definition: research studies to find ways to improve health Definition: research studies to.
Structured Product Labeling Overview
HL7 Now and After PlugIT HL7 Finland , PlugIT, Kuopio, MicroTower Timo Tarhonen, Tietotarha ( Co-chair.
What’s New with CDISC Wayne R. Kubick CDISC CTO.
Physician Perspectives on Subsequent Entry Biologics (SEBs) Michael S. Reilly, Esq. Executive Director, Alliance for Safe Biologic Medicines March 31,
Specimen-Related Classes in BRIDG BRIDG Overview for HL7 O&O WG Conference Call July 1, 2015 Wendy Ver Hoef NCI Contractor.
Initial slides for Layered Service Architecture
11 February 2008NLM BOR WG on Clinical Trials1 Clinical Trials Registration and Results Reporting: Legislative Requirements Jerry Sheehan Assistant Director.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
HL7 Study Data Standards Project Crystal Allard CDER Office of Computational Science Food and Drug Administration February 13,
1 Federal Health IT Ontology Project (HITOP) Group The Vision Toward Testing Ontology Tools in High Priority Health IT Applications October 5, 2005.
1CDISC 2002 RCRIM – Standard Domains Agenda NCI Presentation Standard Domains Working Group Goals Introduction to FDA Information Model (FIM) Discussion:
 BRIDG R3.0.2 was released in August 2010  The BRIDG Model passed the initial ISO Joint Initiative Council ballot as a Draft International Standard (DIS)
Second Annual Japan CDISC Group (JCG) Meeting 28 January 2004 Julie Evans Director, Technical Services.
1 RCRIM Vocab-BRIDG Session Wednesday, Session Q2 19 September 2007.
3 June 2010National Academies - BRDI1 Research Data and Information: Recent Developments and Continuing NIH Interests Jerry Sheehan Assistant Director.
RCRIM Off-cycle Meeting Barbara Tardiff, Randy Levin and Ed Tripp, co-chairs.
Dave Iberson-Hurst CDISC VP Technical Strategy
Briefing: HL7 Working Group Meeting Update for the VCDE Community Dianne M. Reeves Associate Director, Biomedical Data Standards NCI CBIIT VCDE Meeting.
Networking and Health Information Exchange Unit 7d Supporting Standards for EHR Application.
Regulated Product Submission HL7 Update Wednesday January 10 th, 2007 Jason Rock
Networking and Health Information Exchange Unit 5b Health Data Interchange Standards.
Health IT Workforce Curriculum Version 1.0 Fall Networking and Health Information Exchange Unit 3b National and International Standards Developing.
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.
Labeling and Electronic Initiatives Rachel E. Behrman M.D., M.P.H. Deputy Director, Office of Medical Policy CDER FDA Science Board, April 15, 2005.
FDA Standards Development and Implementation Randy Levin, M.D. Director, Office of Information Management Center for Drug Evaluation and Research Food.
CDISC – 17/12/2012 Carine Javierre Nathalie SABIN.
October 28, F OOD AND DRUG ADMINISTRATION AMENDMENTS ACT OF 2007 (FDAAA) and Risk Evaluation and Mitigation Strategies (REMS) Presented to the Ninth.
1 CDISC HL7 Project FDA Perspective Armando Oliva, M.D. Office of Critical Path Programs FDA.
BRIDG Update HL7 Working Group Meeting Phoenix, Arizona 20 January 2010 Biomedical Research Integrated Domain Group.
BRIDG Update May HL7 Working Group Meeting 5 May
BRIDG Update RCRIM Working Group Meeting Rio de Janeiro 17 May 2010 Julie Evans Senior Director, Technical Services, CDISC Wendy Ver Hoef Senior Analyst,
May 2007 CTMS / Imaging Interoperability Scenarios March 2009.
Challenges and issues with information sharing: The four pillars of semantic interoperability Douglas B. Fridsma, MD, PhD, FACP University of Pittsburgh.
© Copyright IBM 2007DIA ERS SIAC Presentation, January 2008 The HL7 RPS and SPL Standards - A High Level View Terry Hardin Sr. IT Architect Emerging Software.
Regulated Product Submission Eileen M. Girten, MS i3 Statprobe 1DIA Education SIAC.
Submission Standards: The Big Picture Gary G. Walker Associate Director, Programming Standards, Global Data Solutions, Global Data Management.
Dave Iberson-Hurst CDISC VP Technical Strategy
Networking and Health Information Exchange
Clinical Interoperability Council Working Group (CIC)
Secondary Uses Primary Use EHR and other Auhortities Clinical Trial
BR&R Biomedical Research & Regulation
Clinical Observation Interoperability March 18, 2008
Presentation transcript:

Joint TC Meeting: EHR – RCRIM RCRIM Overview HL7 Working Group Meeting January, 2007 Presented by: Ed Tripp Program Director, eSubmissions Abbott (RCRIM TC Co-Chair)

© HL Agenda RCRIM Overview / History Project / Standards Portfolio Project Briefing: SPL (Structured Product Labeling) RPS (Regulated Product Submission) BRIDG Domain Analysis Model RCRIM / Clinical R&D perspective on EHR

© HL RCRIM Overview / History RCRIM – Regulated Clinical Research Information Management (Technical Committee) Formed as SIG in 2001, as TC in 2002 (joint effort between CDISC, FDA, and pharma industry) Mission This committee supports the HL7 mission to create and promote its standards by developing standards to improve or enhance information management during research and regulatory evaluation of the safety and efficacy of therapeutic products or procedures worldwide. RCRIM Sponsors the Patient Safety Special Interest Group (PSSIG)

© HL RCRIM Standards Domain: Public Health Individual Case Safety Report (ICSR) Generic Incident Notification (GIN) Domain: Regulated Products Structured Product Labeling (SPL) Regulated Product Submission (RPS) Domain: Regulated Studies AnnotatedECG (aECG) Clinical Trial Laboratory (CT Lab) Stability Study

© HL Project Portfolio Clinical Trial Registries Clinical Genomics Protocol Representation BRIDG (Domain Analysis Model) RCRIM Vocabulary

© HL RCRIM Project Briefing – SPL Business Driver: US HHS Directive - Develop standard for communicating the content of drug product labeling in both a human and machine-readable format to serve as the basis of a national repository Create national repository of all current approved labeling on National Library of Medicine DailyMed website DailyMed serves as the official source of approved labeling for prescribing physicians, patients and healthcare providers Based on HL7 Clinical Document Architecture (CDA) SPL Version 3 complies with new FDA Physician Labeling Rule, and includes encoded Highlights section, among other features. V1 mandatory after Oct 31, 2005 for all USPI labeling submissions V3 mandatory in US after June 30, 2006 for all new indications and efficacy supplements (with multi-year phase-in for remaining types of labeling applications)

© HL RCRIM Project Briefing – RPS Messaging standard (approved as HL7 DSTU) for submitting product information to regulatory authorities Message that can carry an ICH CTD submission and other submission types for drugs, device, veterinary products, food additives and other regulated products. RPS Storyboards include initial submissions, updates, amendments, withdrawals, referencing other submissions, etc. Testing of draft standard currently in progress Testing team members representing pharmaceuticals, med devices, vendors and associated divisions from FDA

© HL RCRIM Project Briefing – BRIDG BRIDG stands for "Biomedical Research Integrated Domain Group". Domain analysis model for the clinical research domain to harmonize clinical research standards among each other and to harmonize standards between clinical research and healthcare The BRIDG model defines standard entities, roles, attributes, and activities for the business processes in standard clinical trials. It could be used as a core data standard for managing the workflow in clinical trials and for generating clinical trial software applications that share the same semantics and thus can exchange data more readily. Mon, Donald T. "Defining the Differences between the CPR, EMR, and EHR. Journal of AHIMA 75, no.9 (October 2004): 74-75,77

© HL RCRIM / Clinical R&D Perspective on EHR Potential Touch Points: Clinical Trials Subject Recruitment / Enrollment Case Report Form data population Patient Record Creation Adverse Event Reporting Clinical Decision Support

Questions?

© HL BRIDG (cont.) Existing Standards Harmonization Existing CDISC msg BRIDG model UML submodel Existing object model UML submodel Existing HL7 message CC B\B\ B A Process A Harmonize existing HL7 DMIM for regulated clinical research Process B extract domain knowledge from existing messages and systems into formal UML models Process C Harmonize and merge UML models into BRIDG

© HL BRIDG (cont.) New Message and Application Development Process D Generate a release of BRIDG for formal requirements traceability with vetting within stakeholder organizations Process E HL7 message generation using HL7 mechanisms Process F Application development with annotation, semantic connector, UML loader DMIM BRIDG model BRIDG model release version X E D HL7 message generation F Annotated UML model App Development